Format

Send to

Choose Destination
Neural Plast. 2016;2016:4292585. doi: 10.1155/2016/4292585. Epub 2016 Dec 27.

A Randomised Controlled Trial of Efficacy of Cognitive Rehabilitation in Multiple Sclerosis: A Cognitive, Behavioural, and MRI Study.

Author information

1
Clinical Imaging Sciences Centre, Brighton and Sussex Medical School, Falmer, UK.
2
Department of Psychology, Royal Holloway, University of London, London, UK.
3
Department of Neurology, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.

Abstract

Aim. To explore the efficacy of home-based, computerised, cognitive rehabilitation in patients with multiple sclerosis using neuropsychological assessment and advanced structural and functional magnetic resonance imaging (fMRI). Methods. 38 patients with MS and cognitive impairment on the Brief International Cognitive Assessment for MS (BICAMS) were enrolled. Patients were randomised to undergo 45 minutes of computerised cognitive rehabilitation using RehaCom software (n = 19) three times weekly for six weeks or to a control condition (n = 19). Neuropsychological and MRI data were obtained at baseline (time 1), following the 6-week intervention (time 2), and after a further twelve weeks (time 3). Cortical activations were explored using fMRI and microstructural changes were explored using quantitative magnetisation transfer (QMT) imaging. Results. The treatment group showed a greater improvement in SDMT gain scores between baseline and time 2 compared to the control group (p = 0.005). The treatment group exhibited increased activation in the bilateral prefrontal cortex and right temporoparietal regions relative to control group at time 3 (p < 0.05FWE  corrected). No significant changes were observed on QMT. Conclusion. This study supports the hypothesis that home-based, computerised, cognitive rehabilitation may be effective in improving cognitive performance in patients with MS. Clinical trials registration is ISRCTN54901925.

PMID:
28116167
PMCID:
PMC5223046
DOI:
10.1155/2016/4292585
[Indexed for MEDLINE]
Free PMC Article

Conflict of interest statement

Dr. J. Campbell and Professor M. Cercignani have nothing to disclose. Dr W. Rashid has accepted educational grants and travel bursaries from Genzyme, Biogen-Idec, Novartis, and Teva and has also participated in advisory boards with Bayer, Novartis, Biogen-Idec, and Genzyme. Professor D. Langdon (i) has received research grants from Bayer, Novartis, and Biogen and has also participated in advisory board with Bayer, Novartis, and Teva is also in the speaker Bureau for Teva, Roche, Bayer, Novartis, and Biogen.

Supplemental Content

Full text links

Icon for Hindawi Limited Icon for PubMed Central
Loading ...
Support Center